SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
